CXCL10 and neoplasm: Taken together, these data suggest that the enhancement of tumor-fighting immune cells in the DEN/CCl4-treated Cxcl10−/− mice shapes the tumor microenvironment in a tumor-diminishing manner, which fostering immune surveillance and tumor rejection.